While SGLT2-i and GLP-1RA may offer additive or synergistic benefits in reducing BP and cardiovascular risk, current guidelines do not support their role as first-line antihypertensive agents or early adjunctive therapies over established agents such as thiazide diuretics, renin-angiotensin system (RAS) inhibitors, or calcium channel blockers (CCBs)
Why the Godzilla Nickname
Remember, lasting results take time, and consistent follow-up is key to your success
Theres nothing exotic about the classification system used to categorize the severity of GLP-1 shedding its typically described as mild, moderate, or severe, depending on the extent of thinning and hair loss
You can also contact our support team who will do this for you
[1] Retatrutide for Obesity Management with Sustained, Profound Weight Loss The biggest headline grabbers have come from a Phase 2 trial published in the New England Journal of Medicine